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ABSTRACT: Calmodulin (CaM) is a cytosolic Ca
2+
-binding protein that serves as a control 
element for many enzymes. It consists of two globular domains, each containing two EF hand 
pairs capable of binding Ca
2+
, joined by a flexible central linker region. CaM is able to bind and 




-deplete forms. To study the Ca
2+
-
dependent/independent properties of binding and activation of target proteins by CaM, CaM 
constructs with Ca
2+
 binding disrupting mutations of Asp to Ala at position one of each EF hand 
have been used. These CaM mutant proteins are deficient in binding Ca
2+
 in either the N-lobe EF 
hands (CaM12), C-lobe EF hands (CaM34), or all four EF hands (CaM1234). To investigate 
potential structural changes these mutations may cause we performed detailed NMR studies of 
CaM12, CaM34, and CaM1234 including determining the solution structure of CaM1234. We then 
investigated if these CaM mutants affected the interaction of CaM with a target protein known to 
interact with apoCaM by determining the solution structure of CaM34 bound to the iNOS CaM 
binding domain peptide. The structures provide direct structural evidence of changes that are 
present in these Ca
2+
 deficient CaM mutants and shows these mutations increase the hydrophobic 
exposed surface and decrease the electronegative surface potential throughout each lobe of CaM. 
These Ca
2+
 deficient CaM mutants may not be a true representation of apoCaM and may not 







Calmodulin (CaM) is a small cytosolic Ca
2+
-binding protein able to bind and regulate hundreds 
of different intracellular proteins.
1
 CaM’s structure consists of two globular domains, each 
containing two EF hand pairs capable of binding to Ca
2+
. These two domains are joined by a 
flexible central linker region that allows it to adapt its conformation to optimally associate with 
its intracellular targets.
2
 The EF hand consists of a helix-loop-helix motif, consisting of a 12 
residue long Ca
2+
 binding loop rich in aspartates and glutamates.
3
 In the absence of Ca
2+
 the 
helix-loop-helix motif of the EF hands are in a “closed” conformation, with their hydrophobic 





 ion binds, the helices rearrange into a more “open” conformation, exposing 
hydrophobic patches in each domain that allow CaM to bind to its target proteins.
3,4,6
 CaM is 






 There is 
considerable interest in obtaining a better understanding of the structural basis for CaM’s ability 
to bind and recognize its numerous target proteins.  
Mutant CaM proteins are commonly used to investigate the Ca
2+
-dependent and independent 
properties of CaM binding and activation of target proteins. These include mutation of the Asp 
residue to Ala at position 1 to inactivate Ca
2+
 binding in the EF hand.
10–13
 These CaM mutants 
are unable to bind Ca
2+
 in either the N-terminal lobe EF hands (CaM12; CaM D20A and D56A 
mutations), the C-terminal lobe EF hands (CaM34; CaM D93A and D129A), or all four Ca
2+
-
binding EF hands (CaM1234; mutations at D20A, D56A, D93A and D129A inclusive). Many 
studies have expressed these Asp to Ala CaM mutants in cells to determine the relative 
functional contribution of Ca
2+
 binding to each lobe of CaM.
14–34
 The overexpression of CaM 









 Meaningful interpretation of these investigations should account 
for differences in the structural integrity of the native apoCaM and the CaM mutant proteins 
carrying defective Ca
2+
-binding EF-hands.        
The mutation of D93 and D129 to Ala effectively prevents Ca
2+
 binding to EF hands III and 
IV, however, it has been shown these mutations may cause structural perturbations in the C-
domain.
13
 This suggests that the Ca
2+
-inactivating mutations may cause CaM to adopt a non-
native apo structure. To investigate these potential structural changes we performed detailed 
NMR structural studies of CaM12, CaM34, and CaM1234 in the absence and presence of Ca
2+
. The 
solution structure of CaM1234 was determined to examine the effects of these mutations 
compared to the solution structure of apoCaM. This structure shows that the Asp to Ala mutation 
cause slight structural and electrostatic surface changes throughout each EF hand. 
To further our investigation of these CaM mutants, NMR studies were performed on their 
association with the CaM binding domain from inducible nitric oxide synthase (iNOS). The 




-deplete forms of CaM.
35–37
 
The iNOS enzyme catalyzes the production of nitric oxide (•NO) that acts as a secondary inter- 
and intracellular messenger involved in many physiological processes.
38
 It consists of a 
dimerized oxygenase domain, flanked by two separated reductase domains, that exist in an 
equilibrium of conformations alternating between FAD-FMN electron transfer (input state) and 
FMN–heme electron transfer (output state).
39–41
 CaM activates NOS through the precise 
positioning of the FMN subdomain necessary for the transferring of electrons to the oxygenase 
domain.
41,42
 The iNOS enzyme binds to CaM at basal levels of Ca
2+
 and is transcriptionally 
regulated in vivo by cytokines.
43,44




determine if the Ca
2+
-free N- or C-lobe of CaM was responsible for the Ca
2+
-independent 
association of CaM to iNOS showed that iNOS was active for both in the presence of Ca
2+
, 
whereas in the presence of EDTA CaM34 showed a substantial decrease in iNOS activity.
24
 We 
thus determined the solution structure of CaM34 bound to the iNOS CaM binding domain peptide 
and compared that to the previously determined holoCaM-iNOS complex to provide further 
insight into this decrease in activity. This structure, along with that of CaM1234 showed that the 
Asp to Ala mutations are associated with an increase in surface hydrophobicity and a decrease in 
the electronegative surface potential throughout each lobe of CaM. These structures show these 
mutations may not be a true representation of apoCaM and may not allow for native-like 
interactions of apoCaM with its target proteins. 
EXPERIMENTAL PROCEDURES 
Sample Preparation for NMR Investigation. CaM12, CaM34 and CaM1234 for NMR 
experiments were expressed in E. coli in 1 L of M9 media (11.03 g/L Na2HPO4·7H2O, 3.0 g/L 
KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM CaCl2, 3 μM (NH4)6(MO7)24, 400 μM H3BO3, 30 
μM CoCl2, 10 μM CuSO4, 80 μM MnCl2·4H2O, 10 μM ZnCl2, 10 mM FeSO4, 100 μg/mL 
kanamycin) containing 2 g/L 
13






N CaM was purified as 
previously described.
24
  Purity of the mutant CaM protein (148 residues) was confirmed by ESI-
MS and was judged to be >95% by SDS-PAGE. The human iNOS peptide 
(RREIPLKVLVKAVLFACMLMRK, 22 residues corresponding to residues 510-531 from the 
full length iNOS protein) was synthesized and purchased from CanPeptide Inc. (Montreal, 
Canada). The iNOS peptide used for SPR was synthesized with biotin attached to the N-terminus 









-CaM34 and CaM34-iNOS samples were prepared for NMR experiments 
via a buffer exchange into NMR solution (100 mM KCl, 10 mM CaCl2, 0.2 mM NaN3, 90% 
H2O/10% 
2
H2O) at pH 6.0 using a YM10 centrifugal filter device (Millipore Corp., Billerica, 
USA). The apoCaM12, apoCaM34 and CaM1234 samples were prepared for NMR experiments via 
a buffer exchange into NMR solution (100 mM KCl, 0.2 mM EDTA, 0.2 mM NaN3, 90% 
H2O/10% 
2
H2O) at pH 6.0 using a YM10 centrifugal filter device (Millipore Corp., Billerica, 
USA). All NMR samples contained at least 1 mM CaM in a total volume of 500 μL. The samples 
were transferred into 5 mm NMR sample tubes and stored at 4
o
C until required for NMR 
experiments. NMR experiments on the CaM34-iNOS complex were conducted on samples 





heteronuclear single-quantum coherence (HSQC) spectrum was acquired to monitor complex 
formation.  
NMR Spectroscopy and Data Analysis. NMR spectra were recorded at 25
o
C on Bruker 600 
MHz DRX spectrometers equipped with XYZ-gradients triple-resonance probes (Bruker, 
Billerica, MA, USA). Spectra were analyzed using the program CARA.
45 
Specific assignments 
of the backbone resonances of the CaM12-iNOS and CaM34-iNOS complexes and CaM1234 alone 
were achieved using a combination of three-dimensional triple-resonance experiments, including 
HNCA and CBCA(CO)NH and the previously obtained amide chemical shifts of Ca
2+
 saturated 
CaM with the iNOS peptide as reference.
46–49
 Side chain resonances for the CaM34-iNOS 
complex and CaM1234 alone were assigned using the TOCSY-type HC(C)H-TOCSY and 
(H)CCH- TOCSY experiments.
50
 Specific assignments of the iNOS peptide in the CaM34-iNOS 








Structure Calculation of the CaM34-iNOS Peptide Complex and CaM1234 Alone. Distance 




Cali NOESY- HSQC and 
13
Caro NOESY- HSQC spectra. Distance constraints for the CaM34-iNOS complex were obtained 
from 
15
N NOESY-HSQC and 
13
C NOESY- HSQC, and 
15
N- double-filtered NOESY spectra 




N-CaM34 and unlabeled peptide.
51–53
 In addition, dihedral 
angle restraints were derived from chemical shift analysis with TALOS+. The structure 
calculations of CaM34-iNOS peptide complex and of CaM1234 alone were performed using 
CNSsolve version 1.2 and initiated with an extended conformation file.
54
 The calculation was 
run through several iterations of a standard simulated annealing protocol to minimize the 
energies and the final 20 lowest energy structures were selected. 
Accession Numbers. The coordinates and NMR parameters have been deposited in the Protein 
Data Bank (PDB) and the BioMagResBank (BMRB) and have been assigned PDB entry 5TP5, 
and BMRB accession number 30195 for CaM1234 and PDB entry 5TP6, and BMRB 30196 
accession number for the CaM34-iNOS complex. 
Electrostatics and Hydrophobicity Calculations. Electrostatic potentials of the CaM−iNOS 
and CaM34-iNOS structures were calculated using the APBS (Adaptive Poisson-Boltzmann 
Solver) and PDB2PQR software packages.
55–57
 The hydrophobicity surface was calculated using 
the kdHydrophobicity attribute function of UCSF Chimera version 1.5.3 (build 33475)
58
 
assigning values according to the amino acid hydrophobicity scale of Kyte and Doolittle.
59
 The 
electrostatic potential and hydrophobicity surfaces were viewed in Chimera. 
Surface Plasmon Resonance. SPR experiments were performed with an openSPR instrument 
(Nicoya Lifesciences, Waterloo, Canada) at 25
o
C with a 100 μL loading loop and a constant flow 




a sensor chip functionalized with an immobilized coating of streptavidin. Binding of CaM was 
tested in either saturating Ca
2+
 buffer (30 mM MOPS, 100 mM KCl, pH 7.2 and 0.1 mM CaCl2) 
or 17 nM free Ca
2+
 buffer (30 mM MOPS, 100 mM KCl, pH 7.2, and combination of 10 mM 
EGTA and 10mM CaEGTA to obtain a final 17 nM concentration of free Ca
2+
). CaM was 
injected over the bound biotin-iNOS peptide in concentrations from 10 to 300 nM for 2 minutes 
to allow association. CaM free saturating Ca
2+
 or 17 nM free Ca
2+
 buffer was passed over the 
sensor for 12 minutes to allow dissociation. Following each CaM injection, 10 mM HCl was 
injected to completely dissociate the complex and regenerate the unbound iNOS peptide. 
Analysis of the data was made using Trace Drawer software (Ridgeview Instruments AB) as 
recommended by the manufacturer. Kinetic parameters were calculated using global analysis, 
fitting the data to a simple 1:1 model (A + B  AB) for CaM-, CaM34- and CaM1234- 




NMR Structural Studies Of CaM12 and CaM34 Indicate Possible Structural 




N HSQC experiments were performed to 
determine if significant structural changes occur due to mutations in the four EF hands of CaM. 
The complete backbone assignment of CaM1234 and CaM12 and CaM34 and in the absence and 
presence of Ca
2+
 was completed. These assignments were used to probe potential structural 




N HSQC comparison with apo and holoCaM. 
Comparing the CaM1234 spectrum to that of apoCaM
5
, chemical shift changes induced by the 4 
EF hand mutations appear for the amides throughout all 4 of the Ca
2+
-binding EF hands (Fig. 
1A). The chemical shift differences for CaM12 and CaM34 were calculated to determine if the 




for the mutated EF hands between apoCaM and CaM12, and apoCaM and CaM34. Fig. 1B and C 




N HSQC spectra overlay of 
apoCaM, apoCaM12 and apoCaM34 (Supplemental Fig. S1A). Cross-peaks for amides in the C-
lobe of apoCaM12 overlap with those of apoCaM, however, amides in the N-lobe, specifically the 
residues in the Ca
2+
 binding loops of the EF hands, do not overlap with those of apoCaM. 
Conversely, cross-peaks for amides in the N-lobe of apoCaM34 overlap with those of apoCaM, 
however, amides in the C-lobe, specifically the residues in the Ca
2+
 binding loops of the EF 
hands, do not overlap with those of apoCaM. This data shows that the Asp to Ala mutations not 
only knock out Ca
2+
 binding to the EF hands but also cause potential structural changes.  




N HSQC spectra 




-CaM34 (Supplemental Fig. 1B). As observed for 
apoCaM12, cross-peaks for the majority of amides in the C-lobe of Ca
2+
-CaM12 overlap with 
those of holoCaM, and amides in the N-lobe, specifically the residues in the Ca
2+
 binding loops 
of the EF hands, do not overlap. However, unlike apoCaM12 there are a few residues in the C-
lobe that are calculated to have a chemical shift difference greater than 0.1 ppm.  
Also as observed for apoCaM34, cross-peaks for amides in the N-lobe of Ca
2+
-CaM34 overlap 
with those of holoCaM, and amides in the C-lobe, specifically the residues in the Ca
2+
 binding 
loops of the EF hands, do not. Like Ca
2+
-CaM12, residues in the opposite lobe appear to be 
affected by the mutations also. In the Ca
2+
-CaM34 case there are quite a few N-lobe residues, 
spread throughout the whole domain, that are calculated to have a chemical shift difference 
greater than 0.1 ppm.This data suggests that the Asp to Ala mutations not only knock out Ca
2+
 
binding to the EF hands where the mutations occur, but also cause potential structural changes in 




residues Phe12, Phe16, Leu18, Phe19 and Met36 in EF hand I and the hydrophobic residues, 
Val55, Ala57, Ile63 and Phe65 in the Ca
2+
 binding loop of EF hand II. These structural changes 
appear to not only be located to the specific EF hands that contain the mutation but also to 
residues of the opposite domain, especially in the case of Ca
2+
-CaM34. 
Solution Structure of CaM1234. To probe these potential conformational changes further the 




N HSQC spectrum of CaM1234 
exhibits good resolution and well dispersed signals, indicating a uniform and folded protein 
structure (Supplemental Fig. 2). The three-dimensional solution structure of CaM1234 was 
determined using multidimensional heteronuclear NMR spectroscopy. The structure of the 
complex is based on a large number of experimental constraints and is well-defined. Structure 
and input data statistics are summarized in Table 1. The family of 20 lowest energy structures is 
shown in Fig. 2A and B. Due to the high degree of flexibility of CaM’s central linker it is not 
possible to superimpose both the C and N-lobes at the same time. Superimposing the ensemble 
of structures with respect to the N-lobe backbone atoms shows a fairly well overlapped N-lobe of 
CaM1234, with an r.m.s.d. of 0.4 for the backbone atoms and 0.9 Å for heavy atoms. In contrast, 
superimposing the ensemble with respect to the C-lobe backbone atoms shows a poorer overlap 
for CaM1234, as shown by an r.m.s.d. of 0.8 for the backbone atoms and 1.3 Å for heavy atoms. 
This indicates the N-lobe has a more stable structure than the C-lobe, which has previously been 
reported to have a well-defined hydrophobic core, compared to a C-lobe with a less defined 
hydrophobic core in the apoCaM structures.
4,5
  
Fig. 2C shows the structure consists of 8 helices, and has the characteristic helix-loop-helix 
conformation for each EF hand, as observed in other apo and Ca
2+
-replete structures of CaM.
4,5,60
 




region is shown to be very flexible, as evidenced by the opposite lobe being distributed in 
different conformations relative to the superimposed lobe. This is also supported by the lack of 
long range NOEs observed for the linker residues or between the two lobes.  
CaM1234 Structure Comparison to ApoCaM. The CaM1234 structure was compared to the 
previously determined solution structure of apoCaM (PDB entry 1CFC)
5
 to determine any 
structural changes incurred by the Asp to Ala mutations in position 1 of the four EF hands. Due 
to the highly flexible linker region described above, the two lobes of CaM of the two structures 
were compared separately (Fig. 3). When the two structures were superimposed with respect to 
CaM’s N-lobe backbone atoms (residues 4-70) a r.m.s.d. value of 2.9 Å was found. Fig. 3A and 
B shows the superposition of the N-lobe of CaM1234 and apoCaM. Helix A and the loop region 
connecting the two EF hands overlay quite well in both structures, whereas helix B is shifted 
down compared to apoCaM and the Ca
2+
-binding loop of EF hand I is tilted away from the Ca
2+
-
binding loop of EF hand II. 
When the two structures are superimposed with respect to the C-lobe backbone atoms 
(residues 84-148) a r.m.s.d. value of 2.6 Å was found. Fig. 3C and D shows the superposition of 
the C-lobe of CaM1234 and apoCaM, which displays more subtle changes and less drastic 
conformational changes compared to the N-lobe. The largest differences seen are a bulge of the 
Ca
2+
-binding loop of EF hand III at the Asp93 to Ala mutation site and the tilting inwards of 
helix E. 
Effect of EF Hand Mutations on the Electrostatic and Hydrophobicity Surface Maps. The 
electrostatic surface potential of apoCaM and CaM1234 were calculated using the APBS 
(Adaptive Poisson-Boltzmann Solver) and PDB2PQR software packages and mapped onto the 




negative surface charge observed throughout apoCaM has been drastically reduced throughout 
all 4 EF hands of the CaM1234 structure. The hydrophobicity surface was also calculated, using 
Chimera, and mapped onto the surfaces of apoCaM and CaM1234 (Fig. 4C and F, respectively). 
The mutations have reduced the hydrophilic surface area and increased the hydrophobic surface 
area throughout the two lobes of the CaM1234 structure. 
NMR Structure of CaM34 and the iNOS CaM Binding Domain Peptide Complex. -We 
next determined the solution structure of CaM34 bound to a peptide of a target protein, iNOS, to 
investigate if these CaM mutants affected the interaction of CaM with target proteins known to 




N HSQC spectrum of CaM34 in complex with the 
peptide of the iNOS CaM-binding domain exhibits good resolution and well dispersed signals, 





N HSQC spectrum of the holoCaM complex chemical shift changes induced by 
the C-lobe EF hand mutations appear predominately for the amides coordinating the Ca
2+
 ion in 
EF hands III and IV, with the greatest differences occurring for the amides in the center of the 
Ca
2+
-binding loop (Supplemental Fig. S3B). The majority of the amide resonances of the N-lobe 
show little chemical shift differences, suggesting both complexes have a similar structure of the 
N-lobe bound to iNOS, however, a few meaningful differences are observed. 
The three-dimensional solution structure of CaM34-iNOS complex was determined using 
multidimensional heteronuclear NMR spectroscopy. The structure of the complex is based on a 
large number of experimental constraints and is well-defined. Residues 1− 12 at the N-terminus 
of the iNOS peptide (corresponding to residues 503-514 of full length iNOS) show a lack of 




calculation. The root-mean-square distance (r.m.s.d.) for ordered residues is 1.0 Å for the 
backbone atoms and 1.4 Å for all non-hydrogen atoms (Table 2).  
The family of 20 lowest energy structures is shown in Fig. 5A. This ensemble of structures 
shows a more closely overlapped N-lobe of CaM34 compared to a C-lobe that displays more 
fluctuation in the ensemble of structures. This can be further shown by looking at the r.m.s.d. 
values for each individual lobe of CaM34 in complex with the iNOS peptide. The r.m.s.d. for the 
C-lobe residues is 1.0 Å for the backbone atoms and 1.7 Å for all non-hydrogen atoms, whereas 
it is 0.7 Å for the backbone atoms and 1.2 Å for all non-hydrogen atoms of the N-lobe. The 
CaM34-iNOS complex has a Ca
2+
-replete N-lobe and a Ca
2+
-deplete C-lobe bound to the iNOS 
peptide as shown in Fig. 5B. This structure shows CaM is still able to bind to iNOS with both 
lobes, even when the C-lobe of CaM is Ca
2+
-deplete due to the Asp to Ala mutations.  
CaM34-iNOS Structure Comparison to the holoCaM-iNOS Complex and ApoCaM. When 
the CaM34-iNOS complex structure is compared to the previously determined solution structure 
of the holoCaM−iNOS complex (PDB entry 2LL6)
46
, the N-lobes of CaM and peptide 
orientation are quite similar, however the Ca
2+
 binding loops of EF hands III and IV of the C-
lobe of CaM are structurally different (Fig. 6A-D). When the two structures are aligned with 
respect to CaM34-iNOS’s backbone atoms a r.m.s.d. value of 4.2 Å for the backbone atoms of 
CaM-iNOS was found. When the two structures are aligned with respect to CaM’s N-lobe 
backbone atoms a r.m.s.d. value of 2.5 Å was found, whereas, an r.m.s.d. value of 3.2 with 
respect to the C-lobe backbone atoms was found. The N-lobes of CaM and the iNOS peptide of 
each structure superimpose quite well on each other, whereas the Ca
2+
 binding loops of EF hands 
III and IV of the C-lobe of CaM do not. Even though the C-lobe of CaM34 is Ca
2+
-deplete, the 




the holoCaM-iNOS complex. This is evident from the solution structure and also from the 
NOESY spectra. The inter-residue NOEs observed for the residues of the α-helices of CaM34’s 
C-lobe are very similar to those observed for the same residues in the holoCaM-iNOS complex. 
The Ca
2+
 binding loops of EF hands III and IV are more compact in the holoCaM-iNOS complex 
compared to the CaM34-iNOS complex and the loop region connecting EF hands III and IV is 
closer to the peptide in the CaM34-iNOS complex. The loop region connecting EF hands I and II 
and helix B are also shifted closer to the iNOS peptide. 
When the CaM34-iNOS complex structure is compared to the previously determined apoCaM 
structure (PDB entry 1CFC)
5
, there is structural similarity of the Ca
2+
 binding loop of EF hand 
III of the C-lobes of CaM (Fig. 6E and F). When the two structures are aligned with respect to 
CaM’s EF hand III Ca
2+
-binding loop backbone atoms (residues 93-104) a r.m.s.d. value of 1.1 Å 
was found. When the two structures are aligned with respect to CaM’s C-lobe backbone atoms 
(residues 93-140) a r.m.s.d. value of 3.5 Å was found. The structure and r.m.s.d. values suggest 
the EF hands of the C-lobe adopt a similar Ca
2+
-deplete conformation for the Ca
2+
-binding loop, 
however the overall conformation of the helix-loop-helix motif is similar to the “open” 
conformation observed in the Ca
2+
-replete form (Fig. 6F). 
Effect of EF Hands 3 and 4 Mutations on the Electrostatic and Hydrophobicity Surface 
Maps of the CaM34-iNOS Complex. The electrostatic surface potentials of holoCaM-iNOS and 
CaM34-iNOS were calculated and mapped onto their respective surfaces (Fig. 7A and B). As was 
observed for CaM1234, the EF hand III and IV mutations cause the C-lobe of CaM34 to have a less 
electronegative surface than that of holoCaM-iNOS. Overall the electrostatic surface of the N-
lobe for both the holoCaM-iNOS and the CaM34-iNOS structures are quite similar (Supplemental 




CaM34-iNOS (Fig. 7C and D, respectively) and a slight increase of hydrophobic surface area can 
be observed near the mutation sites in the CaM34-iNOS structure. 
Surface Plasmon Resonance of CaM, CaM1234 and CaM34 with iNOS. The interaction of 
the iNOS peptide with CaM, CaM1234 and CaM34 was further analyzed using SPR. SPR analysis 
allows us to determine the binding kinetics of a protein to a peptide with the advantage of using a 
label-free system. The kinetics of this binding interaction, including the binding affinity, 
association and dissociation rates, was determined by the injection of different concentrations of 
CaM over a surface with an immobilized iNOS peptide.  
Sensorgrams at various CaM concentrations (10 to 300 nM) were obtained at a saturating Ca
2+
 
concentration of 1 mM with the iNOS peptide (Supplementary Fig. S5). The sensorgrams 
consisted of three phases: an association phase, injection of buffer with CaM; a dissociation 
phase, flushing of the flow cell with CaM-free buffer; and a regeneration phase, injection of 10 
mM HCl for complete dissociation of the complex. Sensorgrams were analyzed by a simple 1:1 
(A + B  AB, where A is CaM and B is the immobilized iNOS peptide) fitting model using the 
Tracedrawer software (Ridgeview Instruments AB) (Table 3). 






 and the dissociation 




, giving a dissociation constant, KD, of 1.4 (± 0.01) x 10
-9
 M 
(Table 3) for CaM at saturating Ca
2+
, which is in good agreement with previously reported 




 To mimic the basal Ca
2+ 
normally found in the cell 
SPR experiments were performed at 17 nM free Ca
2+
 concentration since previous structural 
studies have shown little change in overall CaM structure when bound to iNOS under these 




 Sensorgrams were then obtained at the 
17 nM free Ca
2+














 and an apparent KD of 
7.1 (± 1.0) x 10
-9
 M. To evaluate the binding kinetics of the CaM mutants investigated by NMR 
to the iNOS peptide we performed SPR experiments at saturating Ca
2+
. The binding of CaM1234 
to the immobilized iNOS peptide resulted in a KD of 2.9 (± 0.1) x 10
-9
 M with both slower on 





To study the Ca
2+
-dependent/independent properties of binding and activation of target 
proteins by CaM, numerous studies use a series of CaM mutants that inhibit Ca
2+
 binding to the 
EF hands. These include mutation of Asp to Ala at position 1 of each EF hand in the N-lobe or 
C-lobe or both lobes.
10–13
 Many studies have expressed CaM12, CaM34 or CaM1234 in cells to 
determine if the Ca
2+
-independent association of CaM to its target proteins is due to the Ca
2+
-free 
N- or C-lobe of CaM.
14–33
 These point mutations have been reported to result in structural 
changes in the protein in addition to knocking out its ability to bind Ca
2+
. Due to the widespread 
use of these CaM EF mutants, further investigation of their structures in solution was warranted.  
The CaM1234 structure was compared to the previously determined solution structure of 
apoCaM
5
 to determine any structural changes incurred by the Asp to Ala mutations in position 1 
of the four EF hands. The biggest structural change observed is in the Ca
2+
-binding loop of EF 
hand I. In the apoCaM structure the side chain of Asp20 points into the Ca
2+
 binding loop and is 
involved in hydrogen bonds that stabilize the loop. The conversion of Asp to Ala in the CaM1234 
structure causes the Ca
2+
 binding loop to have a less defined structure by eliminating these 
hydrogen bonds and disrupting the antiparallel β-sheets connecting EF hands I and II. This also 






-binding loop of EF hand II also displays structural changes, however these aren’t as 
large as those observed for EF hand I. In the apoCaM structure the side chain of Asp56 is 
exposed to the solvent, thus doesn’t have as large of a role in stabilizing the loop structure and 
could explain the lower degree of structural change. In the CaM1234 structure the substituted 
Ala56 side chain points into the loop, disrupting the α-helix that Asp56 adopted, unraveling the 
loop slightly and tilting helix C towards helix D. The linker region displays similar α-helical 
secondary structure for helices D and E, with a hinge region at residue 80 for both structures.  
As in the case of EF hand I, the side chain of Asp93 of EF hand III points into the loop, 
however, the mutation to Ala doesn’t cause as large of a structure perturbation as Asp20 to Ala. 
The packing of the Ala side chain into the loop toward the other hydrophobic side chain groups 
causes the loop to bulge compared to apoCaM. The Asp129 to Ala mutation causes more subtle 
changes in the Ca
2+
-binding loop of EF hand IV and helix G. The loop region connecting the two 
EF hands has a slightly different conformation due to helix G being tilted inward. Overall the N-
lobe mutations cause more overall conformational changes compared to the C-lobe, as evidenced 
by the higher r.m.s.d. value for the lobe and the aforementioned differences. These structural 
changes also correlate well with the chemical shift differences observed between the structures, 
which shows the N-lobe of CaM1234 has larger differences in the Ca
2+
-binding loops, but fewer 
differences in the rest of the N-lobe, whereas the C-lobe shows lower chemical shift difference 
values in the Ca
2+
-binding loop but a larger amount of subtle differences throughout the whole 
lobe. 
These structural changes also cause electrostatic changes on the surface of CaM, which may 
affect how CaM1234 interacts with CaM’s target enzymes outside of their CaM binding domains. 




enzymes outside of their CaM binding domains are integral for full enzyme activity.
67–71
 Even 
though CaM1234 mimics the Ca
2+
 free nature of apoCaM, the changes in electrostatic surface 
potential may not allow for full native-like apoCaM interactions with CaM’s target proteins. 
The solution structure of CaM34 bound to iNOS was determined to investigate if these CaM 
mutants affected the interaction of CaM with target proteins known to interact with apoCaM. 
The complex of CaM34 with iNOS was chosen for several reasons. First, binding of CaM to 
iNOS is Ca
2+
-independent, so a complex will be formed even with the Ca
2+
-deplete C-lobe. 
Second, it would allow us to determine if the EF hand III and IV mutations cause structural 
changes in the N-lobe as observed from the chemical shift differences between holoCaM and 
Ca
2+
-CaM34 in Fig. 1E. Finally, because in previous iNOS activation studies with the mutant 






The CaM34-iNOS structure was compared to the previously determined solution structures of 
holoCaM-iNOS apoCaM. The N-lobes of CaM34 and the iNOS peptides are quite similar to the 
holoCaM-iNOS structure, whereas the Ca
2+
 binding loops of EF hands III and IV display 
differences between the structures. The mutation of Asp to Ala removes the oxygen ligand 
necessary to coordinate a Ca
2+
 ion and causes the Ca
2+
 binding loops of EF hands III and IV to 
adopt a less compact conformation in the CaM34-iNOS structure. This causes local structural 
changes, such as the loop region connecting EF hands III and IV to move closer to the iNOS 
peptide, and long range structural conformation changes, observed in the loop region connecting 
EF hands I and II and helix B. The loop regions connecting EF hands I and II and connecting EF 
hands III and IV contain multiple hydrophobic residues that pack close together and interact with 




changes in the N-domain of Ca
2+
-saturated CaM34 that were previously observed.
13
 The EF 
hands of the C-lobe of CaM34 have a Ca
2+
-deplete conformation for the Ca
2+
-binding loop 
similar to apoCaM; however the interaction with the highly hydrophobic iNOS peptide causes 
the overall conformation of the helix-loop-helix motifs to be similar to the “open” conformation 
observed in the Ca
2+
-replete form. The mutations also cause a decrease in the electronegative 
surface potential of CaM’s C-lobe, which may cause nonnative-like apoCaM interactions with 
other regions of the iNOS enzyme. These structures can be used to explain previous iNOS 
activity studies using CaM and the Ca
2+
 deficient CaM mutants. 
One of these studies found that iNOS was active for both CaM34 and CaM12, with CaM34 rates 
similar to holoCaM and CaM12 rates similar to apoCaM, in the presence of Ca
2+
, whereas 
CaM1234 produced significantly reduced rates. In the presence of EDTA a substantial decrease in 
iNOS activity was found for wild type CaM and CaM34, whereas no substantial decrease in iNOS 
activity was found for CaM12 or CaM1234.
24
 For full activation of iNOS by CaM it has been 
shown that not only is binding of CaM to iNOS’ CaM binding domain required, but interaction 
of CaM with both the oxygenase and reductase domains of iNOS is also required to stabilize the 
iNOS output state.
69,70,62
 The interaction of CaM with iNOS is largely electrostatic; with the 
positive residues at the heme and FMN domain interfaces interacting with the negative residues 
of CaM’s N- and C-lobes.
68,72,73
 Molecular dynamics, X-ray crystallography and electron cryo-
microscopy studies have been used to determine key interactions between CaM residues and 
residues of the FMN and both heme domains of the homodimer in the input and output states 
(supplemental Table S1).
68,71–73
 Some potential important connections required for full activity of 
iNOS are: Glu47 of CaM with Arg536 of the FMN domain; Asp122 of CaM with Arg83 and 




monomer heme domain. These studies also showed that CaM undergoes conformational 
changes, along with the FMN and heme domains, from the input to the output state. During the 
movement of the FMN domain to the output state the EF hand loops III and IV move by about 2 
Å and 5 Å, respectively, due to the shifting of the CaM binding domain, while the N-lobe has a 
much larger conformational change, due to its interaction with the FMN domain.
73
 All of these 
interactions, in addition to others observed (supplemental Table S1), are kept fully intact in the 
CaM34-iNOS structure. The CaM34 mutation causes the conformation of the C-lobe of CaM to 
resemble that of CaM interacting with the heme domain in the output state, specifically Arg106 
of EF hand III moves about 3 Å and residues Glu122 and Glu127 of EF hand IV move about 6 Å 
and 5 Å, respectively (Fig. 8). Meanwhile, helix E of the C-lobe of CaM34, which is found to 
interact with the FMN domain, does not move relative to holoCaM. The CaM34 mutation may 
cause the C-lobe of CaM to be in a conformation that has interactions which stabilizes the output 
state conformation of the heme domains, while still allowing the unaffected N-lobe of CaM to 
have the conformational movement with the FMN domain that is necessary to facilitate the inter 
domain electron transfer. The N-lobe of the CaM34-iNOS structure is bound to iNOS in the same 
conformation as holoCaM (Figs. 6 and 8), which explains the full activity of iNOS in the 
presence of Ca
2+
. Also the N-lobe of CaM alone has previously been shown to activate the iNOS 
enzyme in the presence of Ca
2+




The reduced iNOS activity observed for CaM34 in the presence of EDTA could be caused by 
the rearrangement of EF hands I and II due to the removal of Ca
2+
 from the N-lobe, which would 
affect the residues of helix C (Fig. 8) that interact with the FMN domain. This conformational 




to the CaM34 mutation, may not allow for the necessary interactions of the N-lobe of CaM to the 
FMN domain of iNOS required for efficient electron transfer, although CaM is still bound to the 
CaM binding domain of the enzyme due to strong hydrophobic interactions. This may prevent 
the FMN conformational change required for efficient electron transfer to the heme domain or 
prevent CaM from stabilizing the FMN to heme electron transfer in the “output” state.
41,71,72,76
   
The structural rationale for the lower activity observed for CaM1234 with iNOS can be 
explained by comparing the structure of apoCaM to CaM1234. Although CaM1234 is still able to 
bind to the highly hydrophobic CaM-binding domain of iNOS, the structural perturbations and 
electrostatic surface potential changes induced by the EF hand mutations may affect how 
CaM1234 interacts with the rest of iNOS, specifically CaM’s N-lobe interaction with the FMN 
domain. The less hydrophilic and less negative electrostatic surface of CaM1234 would affect its 
interaction with the positive surface residues of iNOS at the CaM-FMN interface, which have 
previously been shown to be necessary for full activation of iNOS.
69,72,73
 This would prevent 
CaM’s stabilizing interaction with the FMN and heme domains in the output state of holoCaM 
with iNOS. The lower activity of iNOS with CaM12 in the presence and absence of Ca
2+
 may 
also be due to the structural and electrostatic changes in the CaM N-lobe as discussed above.  
The KD of CaM binding to the iNOS peptide is in good agreement with previously reported values that 




 Previous NMR studies have suggested that at the 17 nM free Ca
2+
 
concentration iNOS increases CaM’s affinity for Ca
2+





binding kinetics at 17 nM free Ca
2+
 concentration are slower than at saturating Ca
2+
 concentrations due to 
CaM having to bind to Ca
2+
 and the iNOS peptide, whereas at the saturating Ca
2+
 concentration CaM is 
already Ca
2+
-replete and in the correct conformation for binding to iNOS. The slower on and off rates 
observed for CaM1234 binding to iNOS compared to CaM at both 17 nM free Ca
2+






concentration could be explained by the structural perturbations introduced in the N-lobe EF Hands that 
prevent CaM from adopting the correct Ca
2+
-replete conformation necessary for optimum binding to 
iNOS. The fully intact N-lobe of CaM34 would explain why it has a higher on rate when binding 
to the iNOS peptide. This is consistent with previous work that has shown only the N-lobe of 
CaM is necessary for its tight association with iNOS.
68,74,75
 
In summary, mutations in the EF hands of CaM to disable Ca
2+
-binding also cause slight 
structural perturbations, shown in this study by the use of NMR spectroscopy. The structure 
determination of CaM1234 revealed that the mutation of Asp to Ala causes the EF hand loops to 
adopt perturbed conformations when compared to apoCaM, with the greatest effect seen in EF 
Hand I. The structure also displayed a less stable C-lobe compared to N-lobe as previously 
observed for apoCaM. To investigate if these mutations also perturb the structure of CaM bound 
to a target peptide the structure of CaM34 bound to the iNOS peptide was determined. The 
mutation of Asp to Ala causes the Ca
2+
 binding loops in the C-lobe EF hands to adopt a 
conformation resembling apoCaM, which causes local structural changes, as shown in the loop 
region connecting EF hands III and IV, and long range structural conformation changes, as 
shown in the loop region connecting EF hands I and II and helix B. These changes may cause 
CaM to adopt conformations not truly representative of apoCaM. This study provides structural 
evidence of changes that are present in CaM mutants with mutations at Asp in position 1 of the 
EF hand. These mutations also increase the hydrophobic exposed surface and decrease the 
electronegative surface potential throughout each lobe of CaM. To investigate whether the small 
structural differences between apoCaM and CaM1234 result in appreciable changes in biding kinetics with 
the iNOS peptide we performed SPR experiments on the different CaM proteins. Both the on and off  






 and saturated Ca
2+
 concentration.  The differences in binding kinetics with CaM at basal Ca
2+
 levels 
are significant as they provide further reason to carefully scrutinize experiments that use CaM1234 to 
represent the Ca
2+
-free form of the protein. These Ca
2+
 deficient CaM mutants may not be a true 
representation of apoCaM and may not allow for native-like interactions of apoCaM with its 
target proteins.  
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Table 1: Statistics for the structural ensemble of CaM1234. 
 CaM1234 
NMR-derived distance and dihedral angle restraints 
NOE constraints short-range (|i 
− j| < 1) 
sequential medium-range 
(1 < |i − j| < 4) 
long-range (|i 
− j| > 4) 
 968 325 205 265 
   Long Range Intra EF NOEs
a 
EF I EF II EF III EF IV 
 45 47 35 31 
   Total  1763 
Dihedral angles from TALOS+ 240 
Total number of restraints 2003 
Structure statistics for the 20 lowest energy structures 
Mean deviation from ideal covalent 
geometry 
 
Bond lengths (Ǻ)  0.009 
Bond angles (deg.) 0.9 
Average pairwise RMSD (Ǻ) for all heavy 










Backbone Atoms  6.3 5.5 0.8 0.4 
Heavy Atoms 6.6 6.0 1.3 0.9 
Ramachandran statistics (%)  
Residues in most favored region  87.4 
Residues in additional allowed regions  11.8 
Residues in generously allowed region  0.0 
Residues in disallowed region 0.7 
a
 Long range NOEs observed between residues in the same EF Hand 
b 
Ordered residue ranges: 4A-20A,24A-57A,61A-79A,81A-92A,101A-112A,117A-129A,132A-147A 
c 
C-lobe residues: 81A-148A 
d 







Table 2: Statistics for the structural ensemble of the CaM34-iNOS peptide complex. 
 CaM34-iNOS Complex 
NMR-derived distance and dihedral angle restraints 
 CaM34 iNOS peptide CaM34-iNOS complex 
NOE constraints    
   short-range (|i − j| < 1) 821 125 N/A 
   sequential 497 52 N/A 
   medium-range (1 < |i − j| < 4) 240 33 N/A 
   long-range (|i − j| > 4) 160 4 82 
   Total  1718 214 82 
Dihedral angles from TALOS+ 262 N/A N/A 
Total number of restraints                                              2276  
Structure statistics for the 20 lowest energy structures 
Mean deviation from ideal covalent 
geometry 
 
Bond lengths (Ǻ)  0.010 
Bond angles (deg.) 1.2 
Average pairwise RMSD (Ǻ) for all heavy 










Backbone Atoms  1.3 1.0 1.0 0.7 
Heavy Atoms 1.7 1.4 1.6 1.2 
Ramachandran statistics (%)  
Residues in most favored region  84.4 
Residues in additional allowed regions  14.4 
Residues in generously allowed region  0.5 
Residues in disallowed region 0.7 
a 
Ordered residue ranges: 5A-42A, 44A-92A, 100A-147A, 517B-528B 
b 
C-lobe residues: 81A-148A 
c 







Table 3. kon and koff rate constants of iNOS target peptide to CaM in the presence of 17 nM 
free Ca
2+


























27.5 ± 0.01 3.9 ± 0.02 1.4 ± 0.01 
CaM1234-iNOS 6.4 ± 0.1 1.9 ± 0.03 2.9 ± 0.1 
CaM34-iNOS  44.2 ± 0.01 8.5 ± 0.04 1.9 ± 0.01 





















CaM-iNOS 20.5 ± 0.04 14.5 ± 0.2 7.1 ± 1.0 
a









FIGURE 1. Chemical shift differences for the amide chemical shifts between (A) CaM1234 and 
apoCaM (B) apoCaM and apoCaM12, (C) apoCaM and apoCaM34, (D) holoCaM and Ca
2+
-
CaM12, and (E) holoCaM and Ca
2+
-CaM34 are shown. The insets in D and E show the chemical 
shift differences of the C-lobe for holoCaM and Ca
2+
-CaM12 and N-lobe for holoCaM and Ca
2+
-
CaM34, respectively. The greatest differences are localized to Ca
2+
 binding loops where each 
mutation is present. In the presence of Ca
2+
 some chemical shift differences occur for the lobe 




N chemical shift changes for each 

















N chemical shifts between the indicated protein. 
FIGURE 2. Solution structure of CaM1234. The superposition of the ensemble of the 20 lowest-
energy calculated solution structures of  CaM1234.(A) The N-terminal domain is superimposed 
against the energy-minimized average structure. (B) The C-terminal domain is superimposed 
against the energy-minimized average structure. (C) Cartoon ribbon view of the energy-
minimized average solution structure of the CaM1234. Residues 1−40 of CaM (EF hand I) are 
colored red, residues 41−79 (EF hand II) purple, residues 80−114 (EF hand III) green, and 
residues 115−148 (EF hand IV) blue. 
FIGURE 3. Comparison of the solution structure of the CaM1234 with the solution structure of 
apoCaM. The solution structures of CaM1234 (dark colors) and apoCaM (light colors, Structure 
from PDB 1CFD (5)) are overlaid. For clarity only the N-lobes of CaM1234 and apoCaM were 
superimposed in A and B and the C-lobes superimposed in C and D. The side chains of Asp in 




superimposed structures are viewed from EF Hand I to IV in panels A to D. The color scheme is 
the same as Fig. 2. 
FIGURE 4. Electrostatic and hydrophobicity surface representations of apoCaM and CaM1234. 
The APBS-calculated electrostatic potential maps projected on the surface of (A, B) apoCaM 
(Solution structure from PDB 1CFD (5)) and (D, E) the CaM1234 solution structure. The 
hydrophobicity surface calculated in chimera, using the Kyte-Doolittle scale, projected onto (C) 
apoCaM and (F) the CaM1234 solution structures. The electrostatic potential maps are colored 
with a chimera color key ranging from red (acidic, −10) to blue (basic, 10). The hydrophobicity 
surface is colored from blue (4.5) for the most hydrophilic, to white, to orange red (-4.5) for the 
most hydrophobic. The mutation sites D20A, D56A, D93A and D129A are labeled and indicated 
by *. 
FIGURE 5. Solution structure of the CaM34-iNOS complex. (A) Superposition of the ensemble 
of the 20 lowest-energy calculated NMR solution structures of CaM34 bound to the iNOS 
peptide. Backbone atom traces of CaM are colored dark blue, and the iNOS peptide colored light 
blue. (B) Cartoon ribbon view of the average solution structure of the CaM34-iNOS complex. 
CaM has the same color scheme as Fig. 2. The peptide is colored lighter blue. 
FIGURE 6.  (A-D) Comparison of the solution structures of the CaM34-iNOS peptide complex 
and the holoCaM-iNOS peptide complex. The solution structures of the CaM34-iNOS peptide 
(dark colors) and holoCaM-iNOS (light colors) are aligned by superimposition of the backbone 
atoms of the N-lobes of CaM and the iNOS peptides viewed along the bound peptide from its C-
terminus (C′) to its N-terminus (N′) in A and subsequently rotated 90° around the vertical axis in 
B. The superposition is viewed along the bound peptide from its N-terminus (N′) to its C-




omitted for clarity. (E, F) Comparison of the C-terminal residues of the solution structures of the 
CaM34-iNOS peptide complex and apoCaM. The solution structures of the CaM34-iNOS peptide 
(dark colors) and apoCaM (light colors) are aligned by superimposition of the backbone atoms of 
the C-lobes of CaM. The superimposed structures are viewed along the EF hand III and IV 
interface in E and viewed along the side of EF Hand IV in F. The N-lobes and the iNOS peptide 
have been removed for clarity. The color scheme is the same as Fig. 2. 
FIGURE 7. Electrostatic and hydrophobicity surface representations of CaM-iNOS and CaM34-
iNOS. The APBS-calculated electrostatic potential maps are projected on the surface of the C-
lobes of the solution structure of the CaM−iNOS peptide complex (A) and solution structure of 
the CaM34-iNOS peptide complex (B). The hydrophobicity surface calculated in chimera, using 
the Kyte-Doolittle scale, projected onto the surface of the C-lobes of the solution structure of the 
CaM-iNOS peptide complex (C) and solution structure of the CaM34-iNOS peptide complex (D). 
The electrostatic potential maps and hydrophobicity surfaces are colored as in Fig. 4. 
FIGURE 8. The solution structure of the CaM34-iNOS peptide (dark colors) and the crystal 
structure of the iNOS oxy-FMN-holoCaM complex (CaM in light colors, iNOS CaM binding 
and FMN domains in yellow) are aligned by superimposition of the backbone atoms of CaM and 
the iNOS CaM binding domain. The side chains of key residues of CaM that interact with iNOS’ 
heme domains and the distance of their shifts are labeled. The color scheme is the same as Fig. 2. 
Calcium ions are shown as orange spheres and labeled. 
 
